This is different from the arthritis induced by citrullinated fibrinogen immunization in BL6, DR4 transgenic, I-A knock out model which relies on DR4 binding of citrullinated peptides to activate citrullinated peptide specific B cells (12). The gene discussed is TNFRSF10A; the disease is arthritic joint disease.